Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
UnIC@RISE,
Department of Surgery and Physiology,
Faculty of Medicine,
UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine
Pedro Mendes-Ferreira has not added Biography.
If you are Pedro Mendes-Ferreira and would like to personalize this page please email our Author Liaison for assistance.
Therapeutic potential of neuregulin-1 in cardiovascular disease.
Drug discovery today Sep, 2013 | Pubmed ID: 23384772
Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology Apr, 2014 | Pubmed ID: 24780128
Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery.
Cardiovascular drugs and therapy Dec, 2014 | Pubmed ID: 25301384
Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Cardiovascular research Jan, 2016 | Pubmed ID: 26503987
Pulmonary arterial hypertension: Basic knowledge for clinicians.
Archives of cardiovascular diseases Oct, 2016 | Pubmed ID: 27595464
Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients.
Experimental physiology Apr, 2017 | Pubmed ID: 28194824
Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Cardiovascular research May, 2018 | Pubmed ID: 29360952
Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Cardiovascular research Jul, 2018 | Pubmed ID: 29584808
Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.
Clinical and experimental pharmacology & physiology 03, 2019 | Pubmed ID: 30339273
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Circulation Feb, 2019 | Pubmed ID: 30586714
The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model.
Scientific reports 09, 2020 | Pubmed ID: 32973263
Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.
European journal of pharmacology Dec, 2020 | Pubmed ID: 33121950
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
Cardiovascular research Nov, 2021 | Pubmed ID: 33483721
Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms.
Cells Feb, 2021 | Pubmed ID: 33672218
The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload.
Cardiovascular research Sep, 2022 | Pubmed ID: 34550326
Cardiac and Pulmonary Vascular Dysfunction in Vitamin D-Deficient -Mutant Rats.
American journal of respiratory cell and molecular biology Sep, 2022 | Pubmed ID: 36047774
The thromboxane receptor antagonist promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload.
Frontiers in cardiovascular medicine , 2022 | Pubmed ID: 36588576
Human-umbilical cord matrix mesenchymal cells improved left ventricular contractility independently of infarct size in swine myocardial infarction with reperfusion.
Frontiers in cardiovascular medicine , 2023 | Pubmed ID: 37342444
University of Porto
Rui Cerqueira*,1,2,
Liliana Moreira-Costa*,1,
Evangelia Beslika1,3,
André Leite-Moreira1,
Joana Silva3,4,
Paula A. da Costa Martins3,
Adelino Leite-Moreira1,2,
André Lourenço1,
Pedro Mendes-Ferreira1
1UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto,
2Department of Cardiothoracic Surgery, Hospital Universitário de São João,
3CARIM School for Cardiovascular Diseases, Maastricht University,
4, Mirabilis Therapeutics
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.